Search

The construction sector of the Kingdom of Saudi Arabia (KSA), valued at USD 152 billion and employing 2.54 million people by 2023, is crucial to its economy. However, it faces challenges such as delays, disputes, and cost overruns. This study aims to address these issues by implementing Building Information Modeling (BIM) in the KSA, based on an extensive literature review highlighting the role and significance of BIM in mitigating construction claims. BIM improves collaboration, communication, and data integration among stakeholders. Hence, this study proposes a comprehensive BIM Package framework comprising Revit Architecture, Microsoft Project, and Cost-X to reduce claims effectively. Validated through a KSA claims case study with a USD 1,870,000 claims value and 360-day delay, the BIM Package significantly reduced the claims value to USD 188,000 and saved 275 days. Interview sessions were conducted to validate the effectiveness of the BIM Package; 95% favored the use of BIM, 86% supported NEC4 contract adoption alongside BIM, 100% acknowledged BIM's potential in reducing design errors, 95% were confident in the case study's accuracy, and 82% were satisfied with data accuracy. This study confirms that BIM is an effective approach for minimizing construction claims in the KSA. [ABSTRACT FROM AUTHOR]

The emergence of new technologies, artificial Intelligence, BANI environment and multidimensional complexity in projects requires project managers to have an innovative instinct to formulate efficient project management practices to achieve project success. Most articles in the extant literature have discussed leadership factors impacting project success; however, leadership behavioural practices encompassing characteristics/dimensions have not been considered and discussed in a unified manner. Therefore, a need arises with an objective for such a study to bridge the gap of a systematic literature review on leadership behavioural practice characteristics and provide a unified summarised effort to understand relationships with project success from relevant studies between 2000 and 2021. A sample of 72 out of 2805 articles was finally selected for rigorous analysis in a seven-step literature review process. This SLR has identified high to moderate levels of tangible managerial interpersonal and emotional behavioural practice characteristics compared to low-level task-oriented and intellectual practices on construction projects. Compelling evidence shows that relationship-building and people-oriented project leaders using effective communication and collaborative working are highly valued compared to taskoriented project leaders on successful construction projects. Effective leadership practices and findings from this SLR will provide a benchmark for future researchers to investigate further construction projects to generalize SLR outcomes on a broader scale. In addition, project organizations can use our identified cluster listings of behavioural practice characteristics during their recruitment process of project professionals. Low-valued soft skills in our analysis need more investigations in future research. [ABSTRACT FROM AUTHOR]

Background: Real‐world evidence is an essential component of evidence‐based medicine. The aim of the BICSTaR (BICtegravir Single Tablet Regimen) study is to assess effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in antiretroviral treatment‐naïve (TN) and treatment‐experienced (TE) people with HIV. Methods: BICSTaR is a prospective, observational cohort study. Participants (≥18 years) are being followed for 24 months. A pooled analysis is presented at 12 months, with the primary endpoint of effectiveness (HIV‐1 RNA <50 copies/mL) and secondary endpoints of safety and tolerability (as per protocol). An exploration of patient‐reported outcome measures using standardized questionnaires is included. Results: Between June 2018 and May 2021, 1552 people with HIV were enrolled across 12 countries. The analysed population comprised 1509 individuals (279 TN, 1230 TE); most were white (76%), male (84%) and had one or more comorbid conditions (68%). Median age was 47 years. After 12 months of B/F/TAF treatment, HIV‐1 RNA was <50 copies/mL in 94% (221/236) of TN participants and 97% (977/1008) of TE participants. Median CD4 cell count increased by 214 cells/μL (p < 0.001) in TN participants and 13 cells/μL (p = 0.014) in TE participants; median CD4/CD8 ratios increased by 0.30 and 0.03, respectively (both p < 0.001). Persistence was high at 12 months (TN, 97%; TE, 95%). No resistance to B/F/TAF emerged. Study drug‐related adverse events occurred in 13% of participants through 12 months, leading to B/F/TAF discontinuation in 6%. Conclusions: The findings of this study provide robust real‐world evidence to support the broad use of B/F/TAF in both TN and TE people with HIV. [ABSTRACT FROM AUTHOR]